Drug Profile
Research programme: cognition disorder therapeutics - Gedeon Richter/Orion
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Gedeon Richter; Orion
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cognition-disorders in Finland
- 16 Jul 2016 No recent reports of development identified for research development in Cognition-disorders in Hungary
- 12 Mar 2013 Early research in Cognition disorders in Finland and Hungary (unspecified route)